Skip to main content

Danaher Value Stock - Dividend - Research Selection

Danaher

ISIN: US2358511028 , WKN: 866197

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company\'s Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians\' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Fewer Deals, Bigger Stakes: Deciphering The 2026 M&A Landscape And The Rise Of Megadeals

2026-03-06

[Latest] Global Microplate Systems Market Size/Share Worth USD 2.88 Billion by 2035 at a 10.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

2026-03-03
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Microplate Systems Market size & share revenue was valued at approximately USD 1.42 Billion in 2025 and is expected to reach USD 1.57 Billion in 2026 and is expected to reach around USD 2.88 Billion by 2035, at a CAGR of 10.7% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scientific Inc.

Danaher Corporation (DHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript

2026-03-03

Pall Corporation Appoints Dr. Roland Folz as President

2026-03-03
Pall Corporation, a Danaher company and a global leader in filtration, separation and purification, announced the appointment of Dr. Roland Folz as President, Pall Corporation, effective March 3, 2026.

1 Profitable Stock to Target This Week and 2 We Avoid

2026-03-03
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

Why Novo Nordisk's Ireland expansion is key to fighting off Eli Lilly

2026-03-02
Novo Nordisk is investing in a facility in Ireland as it expands its production capacities of the newly launched Wegovy pill, the Danish drugmaker said Monday.

Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness

2026-02-28
If you are wondering whether Danaher is priced fairly today, or if the current share price leaves some value on the table, this article is for you. The stock last closed at US$209.94, with returns of 0.2% over 7 days, a 6.5% decline over 30 days, an 8.9% decline year to date, and a 1.7% gain over 1 year, set against a 5 year return of 10.9% and a 3 year return of a 5.0% decline. Recent interest in Danaher has been shaped by ongoing coverage of its position in the pharmaceuticals and biotech...

Dividend Champion, Contender, And Challenger Highlights: Week Of March 1

2026-02-27

Danaher (DHR) Down 4.7% Since Last Earnings Report: Can It Rebound?

2026-02-27
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Where is Danaher Corporation (DHR) Headed?

2026-02-27
Danaher Corporation (NYSE:DHR) is one of the best strong buy healthcare stocks to invest in. Danaher Corporation (NYSE:DHR) announced on February 24 that its Board of Directors approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 24, 2026, to holders of record on March 27, 2026. In […]